RBC Capital analyst Conor McNamara raised the firm’s price target on Thermo Fisher (TMO) to $693 from $689 and keeps an Outperform rating on the shares after its Q4 earnings beat. Fears of weak guidance from the company were laid to rest as the company guided 3%-4% organic growth and 90bps of EBIT margin expansion, the analyst tells investors in a research note. RBC adds that it sees results as positive especially following the disappointing profit guide from mega-cap peer Danaher (DHR).
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target raised to $660 from $632 at Baird
- Thermo Fisher price target raised to $680 from $660 at Wells Fargo
- Thermo Fisher price target raised to $650 from $600 at Citi
- Thermo Fisher price target raised to $620 from $610 at Barclays
- Thermo Fisher Scientific Reports Robust 2024 Financials